AIM ImmunoTech Inc. announced a reverse stock split of 1-for-100, effective June 12, 2025, aimed at increasing the share price to comply with NYSE American listing requirements. This decision follows ...
AIM ImmunoTech Inc. (NYSE American:AIM) announced Friday that it has completed its previously disclosed rights offering, raising approximately $1.8 million in gross proceeds. The company also ...
The resumption of trading on the NYSE American under the symbol "AIM" signifies renewed investor confidence and liquidity for AIM ImmunoTech Inc. The company's focus on developing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results